MONDELEZ INTERNATIONAL INC Common Stock vs Nuwellis Inc — how do they compare? MONDELEZ INTERNATIONAL INC Common Stock trades at $61.48 (market cap $78.85B), while Nuwellis Inc trades at $1.48 (market cap $542.80K). The key difference: MONDELEZ INTERNATIONAL INC Common Stock is far larger — about 145265.3× Nuwellis Inc's market cap, and MONDELEZ INTERNATIONAL INC Common Stock pays a 3.24% dividend while Nuwellis Inc pays none. Which is the better fit depends on your goals.
| MDLZ | NUWE | |
|---|---|---|
Market Cap | $78.85B | $542.80K |
Sector | Consumer Staples | Technology |
52-Week High | $64.99 | $220.50 |
52-Week Low | $51.51 | $1.42 |
Enterprise Value | $99.19B | -$1.27M |
Dividend Yield | 3.24% | — |
Signals from Pluang's Aura AI — not financial advice
MDLZ trades at $61.53, down 1.72% today, with a bullish technical outlook supported by moving averages and oversold RSI signals. The company reported strong Q2 2026 earnings, beating estimates with $0.73 EPS and raising organic sales guidance, driven by growth in emerging markets. Valuation ratios like P/E of 37.75 and P/S of 4.01 reflect premium pricing, while profitability remains solid with an 8.86% net income margin.
The stock offers upside to the $70.50 consensus price target, supported by analyst optimism and institutional buying, but faces risks from reliance on international sales and margin pressures. Earnings momentum and dividend stability provide a favorable outlook, though macroeconomic volatility could challenge growth.
No Aura AI signal available yet.
Trailing returns across standard periods
Mondelez has operated as an independent organization since its split from the former Kraft Foods North American grocery business in October 2012. The firm is a leading player in the global snack arena with a presence in the biscuit (47% of sales), chocolate (32%), gum/candy (10%), beverage (4%), and cheese and grocery (7%) aisles. Mondelez's portfolio includes well-known brands like Oreo, Chips Ahoy, Halls, Trident, and Cadbury, among others. The firm derives around one third of revenue from developing markets, nearly 40% from Europe, and the remainder from North America.
Read more on MDLZ →Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →